Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novel muraminomicin derivatives with potent activity in MRSA infection models

Jan. 20, 2020

Preliminary findings from phase I study of Spero's SPR-206 support advancement of program

Jan. 16, 2020

Henan Tiansheng Taifeng Pharmaceutical Technology discovers compounds for HBV treatment

Jan. 16, 2020

Janssen R&D Ireland and Johnson & Johnson disclose anti-HBV compounds

Jan. 16, 2020

Macrolide resistance mechanism rescues mRNA from ribosome

Jan. 16, 2020

TCP-25 wound gel targets wound infection and inflammation in vivo

Jan. 15, 2020

Remdesivir as a potential new therapeutic option for MERS-CoV

Jan. 14, 2020

ContraFect begins dosing in phase III study of exebacase for S. aureus bacteremia

Jan. 13, 2020

Novartis patents new compounds for leishmaniasis and trypanosomiasis

Jan. 10, 2020

Locus begins phase Ib trial of CRISPR Cas3-enhanced bacteriophage product LBP-EC01

Jan. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...